Megalith Financial Acquisition Corp. (MFAC), ahead of their May 26th shareholder vote to extend their deadline, announced this morning that they have signed a non-binding Letter of Intent to acquire a digital banking platform that, “is among the fastest growing in the country with several million accounts.“
Furthermore, the press release also says that the target company, “features an advanced, purpose-built platform via proprietary technology that provides a full suite of low-cost banking products including checking, savings, and credit cards to millennials and middle-income consumers.“
We don’t yet know the name of the company, and keep in mind that this is still a non-binding LOI, but on the face of it, this transaction sounds interesting. Megalith will be looking to extend their deadline to August 28, 2020, and previously had not included a contribution to trust in the proxy for non-redeeming shareholders. That’s generally a sign of confidence from the team that they believe this will be a well received transaction and are expecting the share price to trade above cash in trust value. The trick is in making sure investors feel the same way about it and that’s hard to do with limited information.
Unfortunately, MFAC can’t fully announce ahead of their vote with a signed definitive agreement, but we’ll know soon enough if this teaser was enough to wet investors’ appetites.
Aimei Health Technology II Co., Ltd (NASDAQ:AHJKU) has filed for a $60 million SPAC ostensibly to pair up with a small cap biotech or medical device target, but its team’s experience both in SPACs and beyond suggest the vehicle will be open to a broad set of potential targets. It is the first SPAC to...
At the SPAC of Dawn The markets got to open one stocking early yesterday, but it was mostly coal as it showed durable goods orders had declined by more than twice as much as expected to -1.1% in November. It wasn’t all signs of naughtiness, however. Amid the numbers that came public one day earlier...
Copley Acquisition Corp has filed to raise a $150 million SPAC to hunt for a technology or lifestyle target in either the Asia Pacific or North America regions. The new S-1 also advances underwriter Clear Street in the league tables as it has backed two of the three latest SPACs to file in December, and...
Translational Development Acquisition Corp. (NASDAQ: TDACU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TDACU”, Monday, December 23, 2024. The new SPAC intends to take a generalist approach in searching for a business combination, but intend to focus on industries that...
At the SPAC of Dawn SPACs have set to have a busy holiday week with three business combination approval votes and eight special meetings for extensions. Teams are trying to get eight of these in the books today, including all three completion votes ahead of Christmas Eve tomorrow. As noted last week, the theme of...